Trans Nasal Insuflation for the Treatment of Snoring (TNI)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00832026|
Recruitment Status : Unknown
Verified January 2009 by Johns Hopkins University.
Recruitment status was: Active, not recruiting
First Posted : January 29, 2009
Last Update Posted : January 29, 2009
This research is being done to examine if a nasal cannula can be used to keep the throat open during sleep, thereby treating sleep apnea.
People with sleep apnea and people who snore without sleep apnea may take part in this study. Sleep apnea is a disorder caused by pauses in breathing due to repetitive closure of the throat. The most common form of treatment for sleep apnea is continuous positive airway pressure (CPAP) therapy. While CPAP therapy remains the simplest and most effective treatment for snoring and sleep apnea, patients have to wear a nasal mask throughout the night. For this reason, patients often have difficulty sticking to therapy.
Participants enrolled in this study will spend 3-nights in a sleep laboratory. In all nights, the investigators will monitor your sleep and your breathing throughout the night. The investigators will apply several electrodes (sensors) to your scalp and face to monitor your sleep and breathing, and other sensors to your chest, abdomen, cheek, and a finger to monitor your breathing and oxygen level.
|Condition or disease||Intervention/treatment|
|Obstructive Sleep Apnea||Device: Trans Nasal Insuflation (TNI) [nasal canula]|
|Study Type :||Observational|
|Estimated Enrollment :||100 participants|
|Official Title:||Trans Nasal Insuflation for the Treatment of Snoring and Obstructive Sleep Apnea|
|Study Start Date :||July 2004|
Patients with diagnosed obstructive sleep apnea
Device: Trans Nasal Insuflation (TNI) [nasal canula]
Trans Nasal Insuflation, or TNI, uses air at flow rates delivered through a small nasal canula to reduce the severity and frequency of sleep apnea events.
By using TNI we hope to increase the amount of air that the patient can breathe during periods of obstructive sleep disordered breathing.
- Change in inspiratory airflow [ Time Frame: 2 nights ]
- Change in sleep apnea severity (AHI) [ Time Frame: 2 nights ]
- Change in Ratio of apnea-to-hypopnea events [ Time Frame: 2-nights ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00832026
|United States, Maryland|
|Johns Hopkins University|
|Baltimore, Maryland, United States, 21224|